A progression analysis of motor features in Parkinson's disease based on the mapper algorithm

Background Parkinson's disease (PD) is a neurodegenerative disease with a broad spectrum of motor and non-motor symptoms. The great heterogeneity of clinical symptoms, biomarkers, and neuroimaging and lack of reliable progression markers present a significant challenge in predicting disease progression and prognoses. Methods We propose a new approach to disease progression analysis based on the mapper algorithm, a tool from topological data analysis. In this paper, we apply this method to the data from the Parkinson's Progression Markers Initiative (PPMI). We then construct a Markov chain on the mapper output graphs. Results The resulting progression model yields a quantitative comparison of patients' disease progression under different usage of medications. We also obtain an algorithm to predict patients' UPDRS III scores. Conclusions By using mapper algorithm and routinely gathered clinical assessments, we developed a new dynamic models to predict the following year's motor progression in the early stage of PD. The use of this model can predict motor evaluations at the individual level, assisting clinicians to adjust intervention strategy for each patient and identifying at-risk patients for future disease-modifying therapy clinical trials.

[1]  Kristen A. Severson,et al.  Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning. , 2021, The Lancet. Digital health.

[2]  Juan Carlos Niebles,et al.  Quantifying Parkinson's disease motor severity under uncertainty using MDS-UPDRS videos , 2021, Medical Image Anal..

[3]  Ling-Yan Ma,et al.  Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers , 2021, Frontiers in Aging Neuroscience.

[4]  S. Lehéricy,et al.  Parkinson Disease Propagation Using MRI Biomarkers and Partial Least Squares Path Modeling , 2020, Neurology.

[5]  O. Monchi,et al.  A Prodromal Brain‐Clinical Pattern of Cognition in Synucleinopathies , 2020, Annals of neurology.

[6]  Nophar Geifman,et al.  Using topological data analysis and pseudo time series to infer temporal phenotypes from electronic health records , 2020, Artif. Intell. Medicine.

[7]  D. Gramotnev,et al.  Parkinson’s disease prognostic scores for progression of cognitive decline , 2019, Scientific Reports.

[8]  David Eargle,et al.  Kepler Mapper: A flexible Python implementation of the Mapper algorithm , 2019, J. Open Source Softw..

[9]  D. Floden,et al.  Predicting early cognitive decline in newly-diagnosed Parkinson's patients: A practical model. , 2018, Parkinsonism & related disorders.

[10]  Sharmila Majumdar,et al.  Using multidimensional topological data analysis to identify traits of hip osteoarthritis , 2018, Journal of magnetic resonance imaging : JMRI.

[11]  B. Hayete,et al.  Large-scale identification of clinical and genetic predictors of Parkinson’s disease motor progression in newly-diagnosed patients: a longitudinal cohort study and validation , 2017, The Lancet Neurology.

[12]  M. Karlsson,et al.  Modeling a Composite Score in Parkinson’s Disease Using Item Response Theory , 2017, The AAPS Journal.

[13]  J. Schott,et al.  Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study , 2017, The Lancet Neurology.

[14]  J. Long,et al.  Predictors of time to initiation of symptomatic therapy in early Parkinson's disease , 2016, Annals of clinical and translational neurology.

[15]  Benjamin S. Glicksberg,et al.  Identification of type 2 diabetes subgroups through topological analysis of patient similarity , 2015, Science Translational Medicine.

[16]  Jean-François Gagnon,et al.  New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. , 2015, JAMA neurology.

[17]  P. Chan,et al.  Heterogeneity among patients with Parkinson's disease: Cluster analysis and genetic association , 2015, Journal of the Neurological Sciences.

[18]  W. Au,et al.  Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9‐year follow‐up study , 2015, European journal of neurology.

[19]  R. D. de Haan,et al.  Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD , 2013, Neurology.

[20]  P. Y. Lum,et al.  Extracting insights from the shape of complex data using topology , 2013, Scientific Reports.

[21]  J. Nutt,et al.  Progression of motor and nonmotor features of Parkinson's disease and their response to treatment. , 2012, British journal of clinical pharmacology.

[22]  G. Carlsson,et al.  Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival , 2011, Proceedings of the National Academy of Sciences.

[23]  T Revesz,et al.  A clinico-pathological study of subtypes in Parkinson's disease. , 2009, Brain : a journal of neurology.

[24]  R. Barker,et al.  The heterogeneity of idiopathic Parkinson's disease , 2002, Journal of Neurology.

[25]  B. Berman,et al.  Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort , 2018, Movement disorders clinical practice.

[26]  Rami Kraft,et al.  Illustrations of Data Analysis Using the Mapper Algorithm and Persistent Homology , 2016 .

[27]  Facundo Mémoli,et al.  Topological Methods for the Analysis of High Dimensional Data Sets and 3D Object Recognition , 2007, PBG@Eurographics.